What is OGN stock price today?

Visit our real-time dashboard for the current OGN stock price and live market data.

Is OGN stock going up or down today?

OGN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy OGN stock now?

The decision to buy OGN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is OGN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for OGN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is OGN stock overvalued or undervalued?

OGN currently trades at a P/E ratio of 3.36, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if OGN is fairly priced.

What is OGN's P/E ratio?

OGN has a price-to-earnings (P/E) ratio of 3.36, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is OGN's market cap?

OGN (Organon & Co) has a market capitalization of $2.52 billion, making it a small-cap stock.

What is OGN's price to book ratio?

Price-to-book ratio for OGN is available on our dashboard along with other valuation metrics.

Does OGN pay dividends?

Yes, OGN pays dividends with a current yield of 0.83%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is OGN's dividend yield?

OGN's dividend yield is 0.83%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is OGN stock a good long-term investment?

OGN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is OGN's revenue growth rate?

Revenue growth data for OGN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for OGN are available on our dashboard with complete income statement analysis.

What are the risks of investing in OGN?

Key risks for OGN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does OGN compare to its competitors?

Compare OGN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize OGN's performance and positioning.

What is OGN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for OGN with bull, base, and bear case scenarios.

What do analysts say about OGN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for OGN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is OGN's next earnings report?

OGN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

OGN - Organon & Co

NYSE * Healthcare * Drug Manufacturers - General

$0.00

+$0.00 (+0.00%)

About Organon & Co

Organon & Co (OGN) common stock

Price Chart

Loading chart...

OGN Key Statistics

Market Cap

$2.52B

P/E Ratio

3.36

Dividend Yield

0.83%

How OGN Compares to Peers

OGN has the lowest P/E ratio in Drug Manufacturers - General, suggesting it may be the most undervalued

OGN is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
OGN(This stock)	$2.52B	3.4	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 2:02 PM EDT

Ready to invest in OGN?

Commission-free trading available. Affiliate links.

OGN Lician Score

10% confidence

5.0/10

Neutral

OGN has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates OGNacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

OGN Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for OGN

Dashboard

Enter a ticker to analyze